- Home
- GRML vs NOMA Comparison
GRML vs NOMA Comparison
Compare GRML & NOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRML | NOMA |
|---|---|---|
| Founded | N/A | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Services-Misc. Amusement & Recreation |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 32.1M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GRML | NOMA |
|---|---|---|
| Price | $15.32 | $1.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 15.3M | 21.5K |
| Earning Date | 05-13-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $6,376.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $1.31 |
| 52 Week High | $18.21 | $10.00 |
Technical Indicators
Market Signals| Indicator | GRML | NOMA |
|---|---|---|
| Relative Strength Index (RSI) | 75.34 | 35.91 |
| Support Level | $0.20 | $1.31 |
| Resistance Level | N/A | $2.47 |
| Average True Range (ATR) | 2.02 | 0.18 |
| MACD | 1.15 | 0.03 |
| Stochastic Oscillator | 80.96 | 33.59 |
Price Performance
Historical ComparisonAbout GRML Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
About NOMA NOMADAR Corp.
Nomadar Corp operates at the intersection of sports and technology, focusing on high-performance training programs and cultural exchange. The company aims to connect athletes, coaches, and fans through inventive technological solutions, enhancing sports development beyond physical borders. It offers services like the High Performance Training (HPT) program and promotes the legacy of iconic athletes. The Company generates revenue through its High Performance Training Program and events management at the JP Financial Stadium.